Northpond Ventures is a multi-billion dollar science-driven venture capital firm based in Cambridge, MA; San Francisco, CA; and Bethesda, MD. Northpond has been named one of the three most active lead biotech investors in 2021 by Crunchbase, and the most active lead investor in life science solutions and molecular diagnostics by Silicon Valley Bank. It is particularly engaged in the research ecosystem, having founded a bioengineering laboratory at Harvard, and sponsored a prize for women entrepreneurs at MIT. It has led over 50 financings over the past several years, with a high percentage having an academic origin. Learn more at npv.vc.
Employees: 11-50
Founded date: 2018
Investment Type: Venture Capital
Investment Stage: Seed; Series A; Series B
Portfolio 6
| Date | Name | Website | Total Raised | Location |
| 27.08.2026 | Faro Healt... | farohealth.com | $57.3M | United Sta... |
| 12.01.2026 | VieCure | viecure.com | $113M | United Sta... |
| 07.02.2023 | Garuda The... | garudatx.com | $184M | United Sta... |
| 06.02.2023 | Slingshot ... | slingshotbio.com | $34M | United Sta... |
| 14.01.2022 | Scitara Co... | scitara.com | $15M | United Sta... |
| 01.05.2021 | Current He... | currenthealth.com | $54.74M | United Sta... |
Mentions in press and media 14
| Date | Title | Description |
| 30.08.2026 | Agentic AI Leader Faro AI Nabs $37.3M Series B for Pharma Expansion | Faro AI raised $37.3 million in Series B funding. Merck Global Health Innovation Fund and S32 co-led the investment. The capital will expand Faro AI's agentic platform. This platform transforms clinical development. It uses structured data ... |
| 27.08.2026 | Faro AI Raises $37.3 Million Series B As Platform Reaches 6 Of World’s 10 Largest Pharma Companies | Faro AI has raised $37.3 million in Series B funding to expand its agentic AI platform for clinical development, as pharmaceutical companies increasingly turn to artificial intelligence to improve clinical trial design and execution. Merck ... |
| 13.01.2026 | VieCure Accelerates AI Precision Oncology with $43 Million Infusion | VieCure secures $43 million. Its AI-powered Halo Intelligence platform is poised to transform community cancer care. This funding addresses critical operational complexities in clinics, which serve most U.S. cancer patients. The platform bo... |
| 12.01.2026 | Mitch Rales Leads $43M Round to Scale VieCure’s AI Oncology Platform | What You Should Know: – VieCure has raised $43M led by Mitch Rales (co-founder of Danaher) and Northpond Ventures. The funding will scale VieCure’s Halo Intelligence™ platform, an AI-powered clinical decision support system that has already... |
| 03.04.2024 | From generative chemistry to computational astrophysics, startups employ new methods to fight cancer | Here are a few startups in the cancer space that made headlines recently The recent revelation of Princess Kate Middleton’s battle with cancer has sent ripples across the globe, reminding us that this disease knows no boundaries of status o... |
| 19.12.2022 | Merck Digital Sciences Studio Announces the Launch of its First Cohort | NEWARK, N.J. (PRWEB) December 19, 2022 On Friday December 16, Merck (NYSE: MRK) today announced the launch of their first biopharmaceutical cohort through the Merck Digital Sciences Studio (MDSS), a collaboration between Merck, Microsoft fo... |
| 22.11.2022 | Opna Bio Launches with $38 Million Series A Financing | |
| 27.07.2022 | Syapse Raises $35M to Expand Learning Health Network | What You Should Know: – Syapse raises $35M led by an affiliate of Innovatus Capital Partners, LLC (Innovatus)to tackle the challenge of understanding, preventing, and treating complex cancers. – The investment will allow Syapse to expand it... |
| 16.05.2022 | BREAKING: Vestaron banks $82m Series C funding for its crop-protecting peptides | US biotech startup Vestaron, which is devleoping biological alternatives to chemical-based crop controls using peptides, has raised $82 million in its Series C funding round. Private investment officer Ordway Selections and Cavallo Ventures... |
| 02.03.2022 | OPT Industries secures $15M to advance 3D printing metamaterials design | Novel materials developer and MIT spin-out OPT Industries has raised $15 million in Series A funding to scale up the development of its novel 3D printing metamaterials and products. The capital injection will also be funneled into scaling u... |
Show more